Christopher J Moody

14PUBLICATIONS
19CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designOrganometallic chemistryCancer therapy (excl. chemotherapy and radiation therapy)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 03, 2024
Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry.

Russell R A Kitson, Dominika Kitsonová, David Siegel

|Jan 20, 2023
In Vitro Anticancer Properties of Novel Bis-Triazoles.

Maysaa M Saleh, Duaa A Abuarqoub, Alaa M Hammad

|Aug 23, 2021
Diazophosphonates: Effective Surrogates for Diazoalkanes in Pyrazole Synthesis.

Katie Ruffell, Frances R Smith, Michael T Green

|Mar 26, 2021
Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer.

Nurul A Abdullah, Martyn Inman, Christopher J Moody

|Mar 05, 2020
Late-Stage Functionalization by Chan-Lam Amination: Rapid Access to Potent and Selective Integrin Inhibitors.

Henry Robinson, Steven A Oatley, James E Rowedder

|Feb 20, 2020
Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage.

Kaouthar Bouzinab, Helen S Summers, Malcolm F G Stevens

Pageof 3

Frequent Collaborators

4 joint publications

William Lewis

4 joint publications

Tracey D Bradshaw

2 joint publications

Andrew Nortcliffe

2 joint publications

Christopher J Hayes